Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Diamant Thaçi(University of Lübeck), Eric L. Simpson(Oregon Health & Science University), Lisa A. Beck(University of Rochester Medical Center), Thomas Bieber(University of Bonn), Andrew Blauvelt(Oregon Medical Research Center), Kim Papp(Probity Medical Research), Weily Soong(Allergy, Asthma and Clinical Research Center), Margitta Worm(Charité - Universitätsmedizin Berlin), Jacek C. Szepietowski(Wroclaw Medical University), Howard Sofen(University of California, Los Angeles), Makoto Kawashima(Tokyo Women's Medical University), Richard Wu(Regeneron (United States)), Steven P. Weinstein(Regeneron (United States)), Neil M.H. Graham(Regeneron (United States)), Gianluca Pirozzi(Sanofi (United States)), Ariel Teper(Sanofi (United States)), E. Rand Sutherland(Sanofi (United States)), Vera Mastey(Regeneron (United States)), Neil Stahl(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Marius Ardeleanu(Regeneron (United States))
Cited by 566
Abstract
Related Papers
No related papers found
Powered by citation graph analysis